This study aims to assess the effectiveness of Maolactin : a protein product derived from bovine colostrum, for improving gastrointestinal health symptoms.
For this study we are looking to enrol 90 adults aged over 18 who are experiencing moderate GI disturbances of the upper GI tract such as reflux, heartburn, regurgitation, nausea, bloating, abdominal pain at least once a week over the last 3 months.
Before the study begins, there's a 1 month pre-study period where participants will asked to complete some questionnaires, a diet diary, collect a stool sample and conduct an extended urine test from home as part of the pre-study data collection period.
Faecal and urine sample collection kits will be posted to you after enrolment. Your urine sample will need to be collected over a period of 6 hours, but can be be done easily from home or anywhere that you have access to a private bathroom. We will guide you through the process and timing via text and email.
Once all your pre-study requirements are completed, you'll attend our clinic in Fortitude Valley for a 30 minute appointment that will include a fasted blood test.
You will be randomised on a chance basis to one of three different groups and allocated your trial product. You will be assigned to 1 of 3 groups:
Group 1 - High dose active group and being allocated the high dose product (500mg/day MaolactinTM)
Group 2- Low dose active group and being allocated the low dose product (250mg/day MaolactinTM)
Group 3 - Placebo group and being allocated the placebo product (0mg/day MaolactinTM)
We won't know which group you are in until the end of the study.
You will take your study product each day for 8 weeks. We'll ask you to complete more questionnaires and diet diaries during this time, and we'll keep in touch to make sure everything is going smoothly.
After 8 weeks on the study product, we'll ask you to repeat the stool and urine samples from your baseline timepoint and then return to our clinic for a final appointment and bloodtest.
Do you have any questions?
This study aims to assess the effectiveness of Maolactin : a protein product derived from bovine colostrum, for improving gastrointestinal health symptoms.
For this study we are looking to enrol 90 adults aged over 18 who are experiencing moderate GI disturbances of the upper GI tract such as reflux, heartburn, regurgitation, nausea, bloating, abdominal pain at least once a week over the last 3 months.
Before the study begins, there's a 28 day pre-study period where participants will asked to complete some questionnaires, a diet diary, collect and post stool and urine samples and attend the Norwest or Darlinghurst (Lvl3, 393 Bourke St) ACL clinic for a pathology test and some basic measurements.
Will you be able to attend one of these ACL locations for your blood test?
Your study product, Faecal and urine sample collection kits will be posted to you after enrolment. Your urine sample will need to be collected over a period of 6 hours, but can be be done easily from home or anywhere that you have access to a private bathroom. We will guide you through the process and timing via text and email.
Please do not start your study product until instructed by your Trial Coordinator as there are a number of tasks that will need to be completed first.
You will be randomised on a chance basis to one of three different groups and allocated your trial product. You will be assigned to 1 of 3 groups:
Group 1 - High dose active group and being allocated the high dose product (500mg/day MaolactinTM)
Group 2- Low dose active group and being allocated the low dose product (250mg/day MaolactinTM)
Group 3 - Placebo group and being allocated the placebo product (0mg/day MaolactinTM)
We won't know which group you are in until the end of the study.
You will take your study product each day for 8 weeks. We'll ask you to complete more questionnaires and diet diaries during this time, and we'll keep in touch to make sure everything is going smoothly.
After 8 weeks on the study product, we'll ask you to collect some final stool samples and then return to ACL for a final blood test.
Do you have any questions?
Screening Questions
I am pleased to inform you that you are eligible to participate in the trial, I will now issue you with your participant ID. Please make a note of this as you will use this on your questionnaires and all your results will only be identifiable by this code.
Participant Details